Delivery Order SPE2DB24D1007-SPE2DB25FCBNJ

Award Date 4/30/25
Potential Completion Date 5/1/25
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,909.51 contract is for the supply of Veltassa 8.4 GM Powder Packets, a specialty medication used for the treatment of hyperkalemia. The contract has a completion date of February 13, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award, valued at $2,485.31, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Veltassa 8.4 GM powder packets, a medication used to treat hyperkalemia. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award is for the delivery of Veltassa 8.4 GM powder packets to the Defense Logistics Agency (DLA). The $1,936.65 firm fixed price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 24, 2024. The contract has an ultimate completion date of October 25, 2024 and is designated as a Delivery Order with no set-aside requirements. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $3,873.30 contract is for the delivery of the pharmaceutical product Veltassa, a 8.4 gram powder packet, to support military treatment programs and facilities. The contract has an ultimate completion date of April 1, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC)...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award is for the delivery of Veltassa 8.4 GM powder packets, a specialty pharmaceutical product, to support military treatment programs and facilities. The delivery order has a ceiling value of $1,291.10 and a period of performance through April 4, 2024. Amerisourcebergen Drug Corp holds an indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Veltassa 8.4 GM powder packets. The $1,082.84 firm-fixed-price contract has a completion date of December 13, 2022 and is not associated with a set-aside program. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Veltassa 8.4 GM powder packets. The firm-fixed-price contract has a ceiling value of $12,212.80 and a period of performance through March 15, 2024. This order is placed under an indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp with a potential value of $999,999,999.00 and a performance period...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Veltassa 16.8 GM Powder Packets, a medication used for the treatment of hyperkalemia. The contract has a ceiling value of $2,714.08 and a period of performance ending on March 21, 2025. This contract is not designated as a set-aside. AmerisourceBergen holds a...
This federal contract award is for the delivery of Veltassa 8.4 GM Powder Packets in quantities of 30 to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The contract has a ceiling value of $2,648.31 and an ultimate completion date of May 16, 2024. It is a firm fixed-price delivery order contract with no set-aside designation....
This federal contract award, valued at $10,763.78, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. The contract is for the supply of Veltassa 16.8 GM Powder Packets, a pharmaceutical product used for medical treatment. This award does not have a...
  • SPE2DB24D1007
    Indefinite Delivery Contract
  • SPE2DB24D1007-SPE2DB25FCBNJ
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,037.15 firm fixed-price contract is for the delivery of Veltassa 8.4 GM powder packets, a medication used to treat hyperkalemia. The contract has an ultimate completion date of May 1, 2025.

AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

The contract award does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor, and there is no information provided about any subcontractors.

Generated 7/30/25, 10:13 AM